| Application no. and date | 04005832.3 (espacenet) (Federated) (European Patent Register), 19990324 | | Patent/reg. no. and date | DK/EP 1468689, 20070418 | | Publication date | 20041020 | | Priority no. and date | US 163769, 19980930, US 163768, 19980930 | | EP pub. no. and date |
EP 1468689 20041020 | | Effective date | | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, Indiana 46285, US | | Applicant ref. no. | P200400646DK00E | | Inventor | Ferguson, Thomas Harry, 1810 East Main
Greenfield, In 46140, US,
Hendriksen, Barry Arnold, Castlewellan
71 Waltham Avenue
Guildford
Surrey GU2 6QE, GB,
Sanchez-Felix, Manuel Vincente, 4468 Thicket Trace
Zionsville, Indiana 46077, US,
Tupper, David Edward, Eli Lilly & Co., Ltd.
Kingsclere Road
Basingstoke
Hampshire RG21 6XA, GB,
Bunnell, Charles Arthur, 7941 Peshewa Drive
Lafayette, Indiana 47905, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61P 25/22 (2006.01) , C07D 495/04 (2006.01) | | Title | 2-methyl-thieno-benzodiazepine formulation | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
